Dot Compliance raises $23 million in Series B funding

Dot Compliance is a life science quality management service provider that provides life science companies with ready-to-use QMS solutions, including quality and compliance practices, by providing life science organizations with out-of-the-box and end-to-end SaaS solutions to Manage all of its quality and compliance needs, enabling it to deliver medical innovations quickly, safely and efficiently. Dot Compliance recently announced that it has raised a $23 million Series B round led by Israel Growth Partners (IGP), with participation from existing investors Vertex Ventures and TPY Capital.

This article is reproduced from:
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.